Reuters logo
BRIEF-Cerenis Therapeutics H1 operating loss narrows to 2.9‍​ million euros
September 12, 2017 / 4:18 PM / 3 months ago

BRIEF-Cerenis Therapeutics H1 operating loss narrows to 2.9‍​ million euros

Sept 12 (Reuters) - CERENIS THERAPEUTICS HOLDING SA :

* H1 OPERATING LOSS EUR 2.9‍​ MILLION VERSUS LOSS OF EUR 14.0 MILLION YEAR AGO

* H1 NET LOSS EUR 0.7 MILLION VERSUS LOSS OF EUR 14.7 MILLION YEAR AGO

* CASH POSITION AT JUNE 30, 2017 EUR ‍​20.3 MILLION VERSUS EUR 32.9 MILLION YEAR AGO

* DID NOT GENERATE ANY REVENUE IN H1 (AS YEAR AGO)

* ‍RESULTS OF PHASE 3 STUDY OF TANGO EXPECTED IN EARLY 2018​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below